Hydroxyzine Pamoate Capsule
Product Images NDC 71610-217

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Hydroxyzine Pamoate (NDC 71610-217). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

71610 0217 30

71610 0217 30
Label for Hydroxyzine Pamoate USP 25 mg capsules, containing 30 capsules per bottle. The label includes the NDC 71610-0217-30 and storage instructions to keep between 20-25 degrees Celsius and to use a USP Controlled Room Temperature. It lists the manufacturer as Patheon Pharmaceuticals Inc., Cincinnati, OH, and the labeler as Aphena Pharma, Cookeville, TN 38506. Marked for prescription use only.*
FDA Label Image

Aphena Pharma Solutions (TN)

FDA Label Image

Chemical Structure And Chemical Formula (Hydroxyzine Pamoate Capsules 1)

Chemical Structure And Chemical Formula (Hydroxyzine Pamoate Capsules 1)
Chemical structure of Hydroxyzine Pamoate showing molecular formulas C21H27ClN2O2 and C23H16O6 as part of the compound's chemical representation.*
FDA Label Image

Logo (Hydroxyzine Pamoate Capsules 2)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.